Original Research

Increased risk of adverse drug events secondary to bevacizumab treatment in patients with advanced or metastatic breast cancer: a meta-analysis of randomized controlled trials

Shin S, Noh Y

Therapeutics and Clinical Risk Management 2018, 14:833-847

Published Date: 4 May 2018